• Relive the 2023 APHL/ISNS NBS Symposium!

    Relive the 2023 APHL/ISNS NBS Symposium!

    Catch up with highlights of the symposium on the APHL blog.

Vision

All babies have a healthier start through newborn screening (NBS) in the US and globally. 

Mission

Driving global NBS systems to excellence by shaping policy, promoting data-driven improvements and pursuing innovations in public health laboratory practice.

 

 

Conferences & Trainingshttps://www.aphl.org/programs/newborn_screening/Lists/Highlighted Content/DispForm.aspx?ID=1Conferences & Trainings<img alt="" src="/PublishingImages/NBS_MolecularTrainingWorkshop2015_8.JPG" style="BORDER:0px solid;" />https://www.aphl.org/programs/newborn_screening/training/Pages/default.aspx, https://www.aphl.org/programs/newborn_screening/training/Pages/default.aspx
Quality Assurancehttps://www.aphl.org/programs/newborn_screening/Lists/Highlighted Content/DispForm.aspx?ID=2Quality Assurance<img alt="" src="/PublishingImages/DSC_0230.jpg" style="BORDER:0px solid;" />https://www.aphl.org/programs/newborn_screening/Pages/quality-assurance.aspx, https://www.aphl.org/programs/newborn_screening/Pages/quality-assurance.aspx
Molecular Resourceshttps://www.aphl.org/programs/newborn_screening/Lists/Highlighted Content/DispForm.aspx?ID=3Molecular Resources<img alt="" src="/PublishingImages/DSC_0234.jpg" style="BORDER:0px solid;" />https://www.aphl.org/programs/newborn_screening/Pages/molecular-resources.aspx, https://www.aphl.org/programs/newborn_screening/Pages/molecular-resources.aspx

 

 

GMAT Deficiency: New Disorder Resourceshttps://www.aphl.org/aboutAPHL/publications/Documents/NBS-NewSTEPs-GAMT-Toolkit.pdfGMAT Deficiency: New Disorder ResourcesLearn how to communicate with and educate key partners when implementing new Guanidinoacetate Methyltransferase (GAMT) deficiency newborn screening tests.
MPS II: New Disorder Resourceshttps://www.aphl.org/aboutAPHL/publications/Documents/NBS-NewSTEPS-MPSII-Toolkit.pdfMPS II: New Disorder ResourcesLearn how to communicate with and educate key partners when implementing new Mucopolysaccharidosis Type II (MPS II) newborn screening tests.
Laboratory Data in NAS Surveillancehttps://www.aphl.org/aboutAPHL/publications/Documents/EH-NAS-Lab-Data.pdfLaboratory Data in NAS SurveillanceExplore the value and utility of laboratory data in Neonatal Abstinence Syndrome (NAS) surveillance.
NewSTEPs 2020 Annual Reporthttps://www.aphl.org/aboutAPHL/publications/Documents/NewSTEPs_Annual_Report_9_22_21.pdfNewSTEPs 2020 Annual ReportLearn more about the activities of the Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) in 2020.

Related Resources - ,resourceswebpart CUSTOMIZE  Related Resources